VI

Vidara Therapeutics International Public Ltd Co

  • CIK: 0001602949
  • EIN: 00-0000000
  • Business address: H.P. HOUSE, 21 LAFFAN STREET, HAMILTON, Bermuda, HM09

Information

  • Mailing address
    H.P. HOUSE, 21 LAFFAN STREET, HAMILTON, Ireland, HM09
  • Phone
    4412951393
  • State location
    Bermuda
  • State of incorporation
    Ireland
  • Fiscal year end
    December 31
  • SIC
    2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
  • Filings
    N/A

About Vidara Therapeutics International Public Ltd Co

Vidara Therapeutics International Public Ltd Co (CIK: 0001602949) is an American company incorporated in the state of Bermuda. Head office is located at H.P. HOUSE, 21 LAFFAN STREET, HAMILTON, Bermuda, HM09. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. Vidara Therapeutics International Public Ltd Co is a public company and trade via Over-The-Counter (OTC).

Old names:

  • Vidara Therapeutics International Ltd from 2014-19-Mar to 2014-28-Jul

Ownership

Updating!

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Vidara Therapeutics International Public Ltd Co

Filings Format Description Filed/Effective File/Film Number
CT ORDER Document Acc-no: 9999999997-20-004096 (33 Act) Size: 122 KB Jul-14-2020

333-197052

201027121
CT ORDER Document Acc-no: 9999999997-18-006942 (33 Act) Size: 13 KB Jul-16-2018

333-197052

18954819
CT ORDER Document Acc-no: 9999999997-17-006862 (33 Act) Size: 12 KB Jun-07-2017

333-197052

17896175
10-Q/A Document

Amendment to Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0001193125-14-333391 (34 Act) Size: 942 KB		 Sep-05-2014

333-197052

141085276
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0001193125-14-321519 (34 Act) Size: 391 KB		 Aug-26-2014

333-197052

141065109
CT ORDER Document Acc-no: 9999999997-14-012661 (33 Act) Size: 101 KB Aug-12-2014

333-197052

141033599
424B3 Document

Prospectus filed pursuant to Rule 424(b)(3)

Acc-no: 0001193125-14-301186 (33 Act) Size: 4090 KB		 Aug-08-2014

333-197052

141025247
EFFECT Document Acc-no: 9999999995-14-002428 (33 Act) Size: 1 KB Aug-07-2014

333-197052

141025495
CORRESP Document

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Acc-no: 0001193125-14-298455 ( Act) Size: 19 KB		 Aug-06-2014

S-4/A Document

Amendment to Registration of securities issued in business combination transactions

Acc-no: 0001193125-14-298293 (33 Act) Size: 4443 KB		 Aug-06-2014

333-197052

141020359
UPLOAD Document Acc-no: 0000000000-14-039501 ( Act) Size: 161 KB Aug-05-2014

S-4/A Document

Amendment to Registration of securities issued in business combination transactions

Acc-no: 0001193125-14-280931 (33 Act) Size: 4181 KB		 Jul-28-2014

333-197052

14995340
CORRESP Document

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Acc-no: 0001193125-14-280939 ( Act) Size: 49 KB		 Jul-25-2014

UPLOAD Document Acc-no: 0000000000-14-037365 ( Act) Size: 183 KB Jul-24-2014

S-4 Document

Registration of securities issued in business combination transactions

Acc-no: 0001193125-14-251327 (33 Act) Size: 7676 KB		 Jun-26-2014

333-197052

14943238
SC 13D Document

Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities

Acc-no: 0001193125-14-120994 ( Act) Size: 132 KB		 Mar-28-2014

425 Document

Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Acc-no: 0001193125-14-106410 ( Act) Size: 42 KB		 Mar-19-2014

Recent 20 filings. View all Vidara Therapeutics International Public Ltd Co filings

Reviews

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Frequently Asked Questions

Tags:

  • Vidara Therapeutics International Public Ltd Co overview
  • Vidara Therapeutics International Public Ltd Co job
  • Vidara Therapeutics International Public Ltd Co stock
  • Vidara Therapeutics International Public Ltd Co ownership
  • Vidara Therapeutics International Public Ltd Co CEO
  • Vidara Therapeutics International Public Ltd Co documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Contineum Therapeutics, Inc.
Update: Mar 16, 2024
Cuprina Holdings (Cayman) LTD
Update: Mar 08, 2024
APRINOIA Therapeutics Inc.
Update: Jan 27, 2024
Zhengye Biotechnology Holding Ltd
Update: Jan 10, 2024
Alto Neuroscience, Inc.
Update: Nov 28, 2023
Mural Oncology plc
Update: Nov 02, 2023

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 4483 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 4747 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 3881 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 4448 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 2285 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 2091 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 1581 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 3948 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 3250 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by